Agora Financial is a company that has been giving financial advice to consumers for more than twenty-five years. The company offers a wide array of services in order to help their clients protect their wealth for future generations. Agora Financial offers many online tools for readers to use to help them make the best decision when it comes to growing their wealth. Agora Financial has over twenty newsletters. Each newsletter deals with a single aspect of the financial markets. These newsletters are designed to help the more than one million readers figure out how to navigate the market in good and bad times.
One investor, in particular, is a dentist named Bob who wants to make sure that he has enough money for his golden years.Bob is a smart fellow who wants to make sure that his investments work for him and not a hotshot broker wanting to make a quick buck. The advisers at Agora Financial can help Bob find the newest opportunities before they hit the mainstream market. Bob can invest early in new ideas and watch his wealth grow. Agora Financial spends more than one million dollars on research costs alone.
They will go around the world to find the latest investments for Bob to look at.The advisors at Agora Financial can help clients get through rough times as well. One example is the mortgage crisis. Agora Financial experts predicted the bust four years before it happened. That way investors could protect their money before the fallout began.With the help of Agora Financial, Bob can rest easy knowing that he has the money for things he needs to pay for and have enough money left in order to enjoy his retirement. This is the way it was meant to be and Bob couldn’t be happier.
Matthew Autterson is a 1980 graduate of Michigan State University with a degree in finance. He also completed the graduate tax program of the University of Denver. Autterson then went on to spend the next 25 years working in financial services. His first job was with the Fiserv subsidiary First Trust Corporation. In 1982, he left to work with Resources Trust Company, a new trust company chartered in Colorado. That company was a New York based Integrated Resources Inc. subsidiary. He became president of the company in 1986.
Resources Trust Company grew to become among America’s largest state-chartered depository trust companies under Matthew Autterson’s leadership. He helped it amass more than $1 billion in deposits and custodial assets in excess of $20 billion. SunAmerica, Inc. acquired Resources Trust Company and other Integrated Resources assets in 1989.
After leaving Resources Trust Company, in 2001 he became the managing partner of GL3B Partners Limited, LLP. The privately-owned, member-operated limited partnership company is focused on investing partnership assets in privately-held operating companies, real estate and marketable securities. In total Matthew Autterson has spent over 25 years working in financial services.
Matthew Autterson has very active in the Colorado business community and has a wide range of philanthropic interests. He’s on the Falci Adaptive Biosystems’ board of directors. The non-profit organization works to help people with neuromotor disabilities. Autterson is also on the board of the Webb-Waring Foundation, the Denver Zoological Foundation and the Denver Zoo. He’s also the Denver Hospice board chairman. Over the decades Autterson has played a leadership role on the boards of countless Colorado businesses and organizations.
When the Denver Zoo was trying to raise funds for a children’s carousel, Autterson use his connections in the financial services industry to get Mellon, Dreyfus and Buck affiliates to put in $50,000 and become a Title Sponsor. He also brought in 6 Premier sponsors that each donated $15,000, 7 Benefactor Sponsors that donated $7,500 each and a list of Corporate Sponsors that made $3,000 donations.
When he was younger Matthew Autterson of the World Presidents Organization and the Young Presidents Organization. He has fulfilled the potential he showed all those many years ago. Today Matthew Auuterson is Chief Executive Officer, president and member of the board of the clinical-stage drug development company CNS Bioscience, Inc. Founded by Scott Falci, M.D. in 2013, the company focuses on developing effective treatments for neuropathic pain.